Ensem Announces the Promotion of Shengfang Jin, Ph D To President & Chief Executive Officer

Jun 05, 2023•about 2 years ago

Company

ENSEM

WalthamBiotechnology

Description

Ensem Therapeutics Inc., a biotechnology company focusing on high value and difficult-to-drug oncology targets, today announced the promotion of Dr. Shengfang Jin to President and Chief Executive Officer, effective immediately. Dr

Company Information

Company

ENSEM

Location

Waltham, Massachusetts, United States

About

ENSEM is a pioneering drug discovery and development company that leverages its unique Kinetic Ensemble® platform to develop innovative small molecule precision medicines for oncology. ENSEM integrates computational and AI deep learning methodologies with advanced experimental techniques to identify non-obvious binding pockets and accelerate structure-based drug design, with a focus on high-value and difficult-to-drug targets.

Related People

Executive Insights

Based on hiring data

New executive impact window

87% of new executives make significant technology decisions within first 100 days

Budget influence

C-level executives control 73% of technology spending decisions

Transformation catalyst

65% of new senior hires launch digital transformation initiatives

Vendor review timeline

New executives typically review existing vendors within 6 months